active

Melatonin

INCI: MELATONIN
CAS 73-31-4 EC 200-797-7
N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide
Limited Data
Insufficient safety data available. Consider enriching this ingredient.
Details

Description

N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide

Purpose

Function

Antioxidant; AhR pathway modulator; anti-pollution active; circadian repair regulator; anti-inflammatory; indole hormone/neurohormone; night repair active; photoprotective antioxidant
Profile

Properties

Silicone
Silicone free
Compliance

Regulatory Status

EU
Permitted
Safety
EXCELLENT
US
Permitted
Absorptionhigh
Sensitizationnone
MoSadequate
NOAEL0.5 mg/kg
ConcernNone
Flags
anti-pollutionahr-modulatorahr-96pct-reductioncircadian-repairnight-cream-activeantioxidantanti-inflammatorycarnosine-synergyblue-light-repairendogenous
Verdict

Melatonin is a compelling dual anti-pollution and circadian repair active. In human skin explant studies, a combination of melatonin + carnosine + Helichrysum italicum extract reduced AhR expression by 96% following PAH and heavy metal mixture exposure — the most potent AhR downregulation result in the literature. AhR is the central mediator of pollution-induced skin damage; suppressing it by 96% would theoretically prevent the entire downstream cascade (CYP1A1, MMP-1, IL-6/IL-8). Additionally, evening blue light exposure suppresses melatonin-mediated nocturnal skin repair; topical melatonin in night creams can partially restore this repair signaling independently of endogenous systemic suppression. Best positioned in anti-pollution night creams at 0.1–0.5%, combined with carnosine and a botanical AhR antagonist.

US Note

Permitted in cosmetics; sold as dietary supplement in the US without restriction; topical cosmetic use permitted; no FDA concentration restrictions for cosmetic application; not a CIR-reviewed cosmetic ingredient as of current data

Assessment

Ratings

Comedogenic0/5
LowHigh
Irritancy0/5
LowHigh
Reference

Identifiers

CAS Number
73-31-4
EC Number
200-797-7
INCI
MELATONIN
Category
active
Updated
Apr 2, 2026